The James Paul Sutton Medical Research Fund provides grants to non-profit organizations dedicated to cancer research or other medical research. The fund prioritizes cancer research over other types of medical studies, reflecting its commitment to advancing breakthroughs in the fight against cancer. The fund is managed by Wells Fargo Bank, N.A., which oversees grant distribution and ensures compliance with funding guidelines.

The funding opportunity is available nationwide, supporting eligible non-profit organizations that qualify as tax-exempt under Section 501(c)(3) of the Internal Revenue Code. The program's primary focus is on health-related research, with grant awards specifically allocated to cancer research or broader medical research initiatives. While organizations conducting other medical research are considered, applications for cancer-related projects receive preference during the evaluation process.

Grants are awarded on an annual basis, with applications accepted year-round. However, for consideration in the annual grant cycle, applications must be submitted by April 1. The review process is conducted in May, at which time funding decisions are finalized. The average total giving per year is approximately $15,000, though specific award amounts for individual grants are not specified.

Applicants are required to submit their applications online, and they will receive an automated email confirming submission. Once awarded, grantees must submit a progress report within six months of receiving funds, unless otherwise specified at the time of the grant award. This requirement ensures accountability and allows the fund to assess the impact of the awarded grants.

This funding opportunity is ideal for non-profit organizations conducting cancer research or other medical research that aligns with the program’s objectives. Organizations seeking funding should ensure that they meet all eligibility criteria and submit their applications by the annual deadline to be considered for funding.